A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52(1):79-104.

Publication Type:

Journal Article

Authors:

Musso, G.; Gambino, R.; Cassader, M.; Pagano, G.

Source:

Hepatology, Volume 52, Issue 1, p.79-104 (2010)

Keywords:

Adult, Antioxidants, Child, complications, Disease, drug therapy, Fatty Liver, Humans, Indicators, Inflammation, Italy, Liver, Middle Aged, pathology, Patients, Publication Bias, radionuclide imaging, Randomized Controlled Trials, Randomized Controlled Trials as Topic, Research, Research Support, Risk, Safety, secondary, therapeutic use, Thiazolidinediones, treatment, Treatment Outcome, Weight Gain, Weight Loss

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/20578268

Export Citation:

RIS Format

Top